Loading...
An argument for broad use of high efficacy treatments in early multiple sclerosis
Two different treatment paradigms are most often used in multiple sclerosis (MS). An escalation or induction approach is considered when treating a patient early in the disease course. An escalator prioritizes safety, whereas an inducer would favor efficacy. Our understanding of MS pathophysiology h...
Na minha lista:
| Udgivet i: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams & Wilkins
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6935832/ https://ncbi.nlm.nih.gov/pubmed/31757815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000636 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|